1.58 USD
▲+0.03+1.67%
盘后 1.40 -11.39%
2026-11-20
市值
$534.52K
市盈率
—
EPS
-46.70
股息率
—
52 周区间
1.13 – 52.00
成交量
63.35K
Beta
2.26
目标价
—
52W 低 1.1352W 高 52.00
价格走势
公司简介
Scinai Immunotherapeutics Ltd., together with its subsidiaries, operates as a biopharmaceutical company in Israel and internationally. It engages in the research and development of IL-17 NanoAb, a VHH-based antibody platform for the treatment of immune-mediated and inflammatory diseases, including psoriasis; and PC111, a human monoclonal antibody for the treatment of pemphigus, Steven Johnson's syndrome, and toxic epidermal necrolysis. The company also offers contract development and manufacturing organization services, such as analytical metho...